Han et al. [33] found that the number of peripheral CD4+ T and CD8+ T lymphocytes in STAD patients can reflect the infiltration status of these lymphocytes in cancer and normal adjacent tissues to a certain extent, and can preliminarily predict immunotherapy response. Here, CD8A is linked to cancer.